The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
Open accessAbstract
Background—: In diabetes mellitus, vascular complications such as atherosclerosis are a major cause of death. The key underlying pathomechanisms are unclear. However, hyperglycemic oxidative stress derived from NADPH oxidase (Nox), the only known dedicated enzyme to generate reactive oxygen species appears to play a role. Here we identify the Nox1 isoform as playing a key and pharmacologically targetable role in the accelerated development of diabetic atherosclerosis. Methods and Results—: Human aortic endothelial cells exposed to hyperglycemic conditions showed increased expression of Nox1, oxidative stress, and proinflammatory markers in a Nox1-siRNA reversible manner. Similarly, the specific Nox inhibitor, GKT137831, prevented oxidative stress in response to hyperglycemia in human aortic endothelial cells. To examine these observations in vivo, we investigated the role of Nox1 on plaque development in apolipoprotein E–deficient mice 10 weeks after induction of diabetes mellitus. Deletion of Nox1, but not Nox4, had a profound antiatherosclerotic effect correlating with reduced reactive oxygen species formation, attenuation of chemokine expression, vascular adhesion of leukocytes, macrophage infiltration, and reduced expression of proinflammatory and profibrotic markers. Similarly, treatment of diabetic apolipoprotein E–deficient mice with GKT137831 attenuated atherosclerosis development. Conclusions—: These studies identify a major pathological role for Nox1 and suggest that Nox1-dependent oxidative stress is a promising target for diabetic vasculopathies, including atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased NOX1 activity is associated with vascular disease, and studies have shown links between high NOX1 levels and hypertension (1015), diabetes (163, 380, 1003), ischemia/reperfusion injury (479), and coronary artery disease (393).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [380]
In the citing paper
“Altogether, the role of NOX1 in cardiovascular disease seems secondary to NOX2, but still significant, as shown in several models (345, 380, 630, 854).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [380]
In the citing paper
“However, NOX4 deletion in the ApoE−/− mouse does not ameliorate diabetes-associated vasculopathy (380).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [380]
In the citing paper
“The results of different studies are contradictory, with examples of improved outcomes for NOX1 deficient mice subjected to high fat diet (854) and diabetic mouse models (380), whereas in other cases, NOX1 deletion did not seem to have an effect (875).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S.-N., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J.-C., Connelly, P. W., & Milstone, D. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11871 · Cited by 1,244
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis
Sorescu, D., Weiss, D., Lassègue, B., Clempus, R. E., Szöcs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012917.74432.66 · Cited by 847
Vascular Adhesion Molecules in Atherosclerosis
Galkina, E., & Ley, K. F. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149179 · Cited by 831
Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase
Schröder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., Kruse, C., Luedike, P., Michaelis, U. R., Weissmann, N., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.267054 · Cited by 622
Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590
Self-citationA Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in Mice
Krege, J. H., Hodgin, J. B., Hagaman, J. R., & Smithies, O. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.1111 · Cited by 587
Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney
Gorin, Y. C., Block, K. L., Hernandez, J., Bhandari, B., Wagner, B., Barnes, J. L., & Abboud, H. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502412200 · Cited by 496
Flagged first, then by citations
Cited by
Sorted by citations
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q., & Griendling, K. K. (2018) · Circulation Research · doi:10.1161/circresaha.117.311401 · Cited by 2,081
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
Self-citationRoles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Network pharmacology: curing causal mechanisms instead of treating symptoms
Nogales, C., Mamdouh, Z. M., List, M., Kiel, C., Casas, A. I., & Schmidt, H. H. H. W. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.11.004 · Cited by 1,251
Self-citationChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Poznyak, A. V., Grechko, A. V., Poggio, P., Myasoedova, V. A., Alfieri, V., & Orekhov, A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051835 · Cited by 1,267
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. M. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 819
NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
Vermot, A., Petit-Härtlein, I., Smith, S. M. E., & Fieschi, F. (2021) · Antioxidants · doi:10.3390/antiox10060890 · Cited by 766
Diabetes and Kidney Disease: Role of Oxidative Stress
Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E., & Jandeleit-Dahm, K. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6664 · Cited by 660
Self-citationThe Role of Oxidative Stress in Atherosclerosis
Batty, M., Bennett, M. R., & Yu, E. (2022) · Cells · doi:10.3390/cells11233843 · Cited by 586
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. “. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 551
Diabetes, oxidative stress and therapeutic strategies
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.05.017 · Cited by 543
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
Self-citationOxidative stress and diabetes: antioxidative strategies
Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., & Zhang, Y. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0729-1 · Cited by 548
NADPH Oxidases in Vascular Pathology
Konior, A., Schramm‐Luc, A., Cześnikiewicz‐Guzik, M., & Guzik, T. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 464
Angiotensin II and Vascular Injury
Montezano, A. C. I., Cat, A. N. D., Rios, F. J. O., & Touyz, R. M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0431-2 · Cited by 412
Self-citationAntioxidant and Anti‐Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
Li, Z., Geng, Y., Jiang, J., & Kong, W. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/289264 · Cited by 400
Anti-inflammatory therapies for atherosclerosis
Bäck, M., & Hansson, G. K. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.5 · Cited by 380
Wang, Q., Zhang, M., Torres, G., Wu, S., Ouyang, C., Xie, Z., & Zou, M.-H. (2017) · Diabetes · doi:10.2337/db16-0915 · Cited by 370
Interrelation between ROS and Ca2+ in aging and age-related diseases
Madreiter‐Sokolowski, C. T., Thomas, C., & Ristow, M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101678 · Cited by 369
Janaszak-Jasiecka, A., Płoska, A., Wierońska, J. M., Dobrucki, L. W., & Kalinowski, L. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00423-2 · Cited by 358
Jha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070810 · Cited by 352
Self-citationAtherosclerotic Plaque Destabilization
Silvestre-Roig, C., de Winther, M. P. J., Weber, C., Daemen, M. J. A. P., Lutgens, E., & Soehnlein, O. (2014) · Circulation Research · doi:10.1161/circresaha.114.302355 · Cited by 346
Oxidative Stress and Human Hypertension: Vascular Mechanisms, Biomarkers, and Novel Therapies
Montezano, A. C. I., Dulak-Lis, M. G., Tsiropoulou, S., Harvey, A., Briones, A. M., & Touyz, R. M. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.008 · Cited by 324
Self-citationEndothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?
Meza, C. A., La Favor, J. D., Kim, D.-H., & Hickner, R. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153775 · Cited by 323
Endothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond, G. R., & Sobey, C. G. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.012 · Cited by 315
Cervantes-Gracia, K., Llanas-Cornejo, D., & Husi, H. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020022 · Cited by 320
Flow-induced reprogramming of endothelial cells in atherosclerosis
Tamargo, I. A., Baek, K. I., Kim, Y., Park, C. J., & Jo, H. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00883-1 · Cited by 306
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Warren, A. M., Knudsen, S. T., & Cooper, M. E. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1624721 · Cited by 245
Self-citationMechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension
Li, Q., Youn, J.-Y., & Cai, H. “. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000587 · Cited by 244
Diabetic nephropathy: Is there a role for oxidative stress?
Sagoo, M. K., & Gnudi, L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.040 · Cited by 237
Protective Factors and the Pathogenesis of Complications in Diabetes
Yu, M. G., Gordin, D., Fu, J., Park, K., Li, Q., & King, G. L. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad030 · Cited by 252
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Wang, N., & Zhang, C. (2024) · Antioxidants · doi:10.3390/antiox13040455 · Cited by 260
Jha, J. C., Ho, F., Dan, C., & Jandeleit-Dahm, K. A. M. (2018) · Clinical Science · doi:10.1042/cs20171459 · Cited by 207
Self-citationOxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes
Charlton, A., Garzarella, J., Jandeleit-Dahm, K. A. M., & Jha, J. C. (2020) · Biology · doi:10.3390/biology10010018 · Cited by 214
Self-citationGray, S. P., Di Marco, E., Kennedy, K., Chew, P., Okabe, J., El-Osta, A., Calkin, A. C., Biessen, E. A. L., Touyz, R. M., Cooper, M. E., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.307012 · Cited by 189
Self-citationOxidative Stress and Hypertensive Diseases
Loperena, R., & Harrison, D. G. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.004 · Cited by 192
Ma, X., Chen, Z., Wang, L., Wang, G., Wang, Z., Dong, X., Wen, B., & Zhang, Z. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00782 · Cited by 202
Gorin, Y., Cavaglieri, R. C., Khazim, K., Lee, D.-Y., Bruno, F., Thakur, S., Fanti, P., Szyndralewiez, C., Barnes, J. L., Block, K., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00396.2014 · Cited by 183
Self-citationThe NADPH oxidase Nox4 has anti-atherosclerotic functions
Schürmann, C., Rezende, F., Kruse, C., Yasar, Y., Löwe, O., Fork, C., van de Sluis, B., Bremer, R., Weißmann, N., Shah, A. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv460 · Cited by 178
ROS signaling and redox biology in endothelial cells
Panieri, E., & Santoro, M. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1928-9 · Cited by 168
Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease
Zhang, Z., Dalan, R., Hu, Z., Wang, J., Chew, N., Poh, K. K., Tan, R., Soong, T. W., Dai, Y., Ye, L., et al. (2022) · Advanced Materials · doi:10.1002/adma.202202169 · Cited by 174
Therapeutic potential of nadph oxidase 1/4 inhibitors
Teixeira, G., Szyndralewiez, C., Molango, S., Carnesecchi, S., Heitz, F., Wiesel, P., & Wood, J. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13532 · Cited by 163
Self-citationLv, W., Booz, G. W., Fan, F., Wang, Y., & Roman, R. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00105 · Cited by 161
Recent novel approaches to limit oxidative stress and inflammation in diabetic complications
Pickering, R. J., Rosado, C. J., Sharma, A., Buksh, S., Tate, M., & de Haan, J. B. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1016 · Cited by 164
Chang, W., Chen, L., & Hatch, G. M. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0107 · Cited by 159
Novel targets of antifibrotic and anti-inflammatory treatment in CKD
Declèves, A., & Sharma, K. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.31 · Cited by 158
Fan, X., Wang, C., Jin, Y., Liu, Q., Meng, Q., Liu, K., & Sun, H. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.23697 · Cited by 154
Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment
Poznyak, A. V., Grechko, A. V., Orekhova, V. A., Chegodaev, Y. S., Wu, W., & Orekhov, A. N. (2020) · Biology · doi:10.3390/biology9030060 · Cited by 188
The Role of Oxidative Stress and Autophagy in Atherosclerosis
Perrotta, I. D., & Aquila, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/130315 · Cited by 148
Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation
Totoń‐Żurańska, J., Mikolajczyk, T. P., Saju, B., & Guzik, T. J. (2024) · Clinical Science · doi:10.1042/cs20220797 · Cited by 156
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo, S., Meijles, D. N., & Pagano, P. J. (2016) · Clinical Science · doi:10.1042/cs20150087 · Cited by 147
TFEB inhibits endothelial cell inflammation and reduces atherosclerosis
Lu, H., Fan, Y., Qiao, C., Liang, W., Hu, W., Zhu, T., Zhang, J., & Chen, Y. E. (2017) · Science Signaling · doi:10.1126/scisignal.aah4214 · Cited by 141
Diabetic Complications and Oxidative Stress: A 20-Year Voyage Back in Time and Back to the Future
Iacobini, C., Vitale, M., Pesce, C. M., Pugliese, G., & Menini, S. (2021) · Antioxidants · doi:10.3390/antiox10050727 · Cited by 161
NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy
Jha, J. C., Banal, C., Okabe, J., Gray, S. P., Hettige, T., Chow, B. S. M., Thallas‐Bonke, V., de Vos, L. C., Holterman, C. E., Coughlan, M. T., et al. (2017) · Diabetes · doi:10.2337/db16-1585 · Cited by 145
Self-citationInflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway
Peiró, C., Romacho, T., Azcutia, V., Villalobos, L. A., Fernández, E., Bolaños, J. P., Moncada, S., & Sánchez‐Ferrer, C. F. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0397-2 · Cited by 147
Pagano, G., Talamanca, A. A., Castello, G., Cordero, M. D., d’Ischia, M., Gadaleta, M. N., Pallardó, F. V., Petrović, S. Ž., Tiano, L., & Zatterale, A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/541230 · Cited by 139
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications
Casas, A. I., Dao, V. T.-V., Daiber, A., Maghzal, G. J., Di Lisa, F., Kaludercic, N., Leach, S., Cuadrado, A., Jaquet, V., Seredenina, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6433 · Cited by 136
Self-citationNADPH Oxidases and Mitochondria in Vascular Senescence
Salazar, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051327 · Cited by 133
Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction
Sukumar, P., Viswambharan, H., Imrie, H., Cubbon, R. M., Yuldasheva, N. Y., Gage, M., Galloway, S. L., Skromna, A., Kandavelu, P., Santos, C. X. C., et al. (2013) · Diabetes · doi:10.2337/db12-1294 · Cited by 136
NADPH oxidases and vascular remodeling in cardiovascular diseases
García‐Redondo, A. B., Aguado, A., Briones, A. M., & Salaíces, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.015 · Cited by 139
Nox, Reactive Oxygen Species and Regulation of Vascular Cell Fate
Burtenshaw, D., Hakimjavadi, R., Redmond, E. M., & Cahill, P. A. (2017) · Antioxidants · doi:10.3390/antiox6040090 · Cited by 136
From Flies to Men: ROS and the NADPH Oxidase in Phagocytes
Moghadam, Z. M., Henneke, P., & Kolter, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.628991 · Cited by 146
Langbein, H., Brunssen, C., Hofmann, A., Cimalla, P., Brux, M., Bornstein, S. R., Deussen, A., Koch, E., & Morawietz, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv564 · Cited by 133
Nox/Duox Family of NADPH Oxidases: Lessons from Knockout Mouse Models
Sirokmány, G., Donkó, Á., & Geiszt, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.006 · Cited by 138
IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
Peiró, C., Lorenzo, Ó., Carraro, R., & Sánchez‐Ferrer, C. F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00363 · Cited by 140
Ferroptosis: Mechanisms and role in diabetes mellitus and its complications
Liu, P., Zhang, Z., Cai, Y., Li, Z., Zhou, Q., & Chen, Q. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102201 · Cited by 137
Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors
Hasheminasabgorji, E., & Jha, J. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111602 · Cited by 126
Obesity, oxidative stress, and fibrosis in chronic kidney disease
Sharma, K. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.21 · Cited by 128
Nox as a target for diabetic complications
Gorin, Y. C., & Block, K. L. (2013) · Clinical Science · doi:10.1042/cs20130065 · Cited by 122
Redox signaling at the crossroads of human health and disease
Zuo, J., Zhang, Z., Luo, M., Zhou, L., Nice, E. C., Zhang, W., Wang, C., & Huang, C. (2022) · MedComm · doi:10.1002/mco2.127 · Cited by 123
Kumar, S., Kang, D. W., Rezvan, A., & Jo, H. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.47 · Cited by 118
Manea, S., Constantin, A. L., Manda, G., Sasson, S., & Manea, A. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.012 · Cited by 119
Updates of reactive oxygen species in melanoma etiology and progression
Liu, F., Dellinger, R. W., & Meyskens, F. L. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.007 · Cited by 119
Ji, X., Li, C., Ou, Y., Li, N., Yuan, K., Yang, G., Chen, X., Yang, Z., Liu, B., Cheung, W. W., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.06.029 · Cited by 112
NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis
Lozhkin, A. P., Vendrov, A. E., Pan, H., Wickline, S. A., Madamanchi, N. R., & Runge, M. S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.12.004 · Cited by 110
Gray, S. P., Jha, J. C., Kennedy, K., van Bommel, E. J. M., Chew, P., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4215-5 · Cited by 109
Self-citationPolyphenol compounds and PKC signaling
Das, J., Ramani, R., & Suraju, M. O. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.06.022 · Cited by 109
Lu, C., Yang, Y., Li, C., Liu, K., Lii, C., & Chen, H. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.024 · Cited by 107
Dludla, P. V., Joubert, E., Muller, C. J. F., Louw, J., & Johnson, R. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0200-8 · Cited by 104
Teixeira-Santos, L., Albino‐Teixeira, A., & Pinho, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105280 · Cited by 108
NADPH oxidases: redox regulation of cell homeostasis and disease
Kračun, D., Lopes, L. R., Cifuentes-Pagano, E., & Pagano, P. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00034.2023 · Cited by 114
Jing, Y. J., Ni, J., Ding, F. H., Fang, Y. H., Wang, X. Q., Wang, H. B., Chen, X. N., Chen, N., Zhan, W., Lu, L., et al. (2015) · Kidney International · doi:10.1038/ki.2015.287 · Cited by 103
DeVallance, E., Li, Y., Jurczak, M. J., Cifuentes-Pagano, E., & Pagano, P. J. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7674 · Cited by 103
Role of reactive oxygen species in atherosclerosis: Lessons from murine genetic models
Nègre‐Salvayre, A., Guerby, P., Gayral, S., Laffargue, M., & Salvayre, R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.011 · Cited by 102
The opposing roles of NO and oxidative stress in cardiovascular disease
Ritchie, R. H., Drummond, G. R., Sobey, C. G., Silva, T. M. D., & Kemp‐Harper, B. K. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.017 · Cited by 99
The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side
Togliatto, G., Lombardo, G., & Brizzi, M. F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091988 · Cited by 99
Meijles, D. N., Sahoo, S., Ghouleh, I. A., Amaral, J. H., Bienes-Martínez, R., Knupp, H. E., Attaran, S., Sembrat, J., Nouraie, M. S., Rojas, M. M., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaj1784 · Cited by 100
Nox4 as a novel therapeutic target for diabetic vascular complications
Wang, D., Li, J., Luo, G., Zhou, J., Wang, N., Wang, S., Zhao, R., Cao, X., Ma, Y., Liu, G., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102781 · Cited by 98
Oxidative Stress in Kidney Injury and Hypertension
Arendshorst, W. J., Vendrov, A. E., Kumar, N., Ganesh, S. K., & Madamanchi, N. R. (2024) · Antioxidants · doi:10.3390/antiox13121454 · Cited by 108
KONES, R. J. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s37119 · Cited by 91
APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury
Joo, J., Min, H. S., Kim, K., Kim, J. E., Ghee, J. Y., Kim, H. W., Lee, J. E., Han, J., Lee, G.-Y., Ha, H., et al. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.2 · Cited by 87
Are reactive oxygen species still the basis for diabetic complications?
Marco, E. D., Jha, J. C., Sharma, A., Wilkinson‐Berka, J. L., Jandeleit-Dahm, K. A. M., & de Haan, J. B. (2015) · Clinical Science · doi:10.1042/cs20150093 · Cited by 86
Self-citationLinking RAGE and Nox in diabetic micro- and macrovascular complications
Koulis, C., Watson, A. M. D., Gray, S. P., & Jandeleit-Dahm, K. A. M. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.01.006 · Cited by 86
Self-citationThe Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84
Butyrate modulates diabetes-linked gut dysbiosis: epigenetic and mechanistic modifications
Noureldein, M. H., Bitar, S., Youssef, N., Azar, S., & Eid, A. A. (2020) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0132 · Cited by 84
Obesity as a premature aging phenotype — implications for sarcopenic obesity
Nunan, E. L., Wright, C. L., Semola, O. A., Subramanian, M., Balasubramanian, P., Lovern, P. C., Fancher, I. S., & Butcher, J. T. (2022) · GeroScience · doi:10.1007/s11357-022-00567-7 · Cited by 83
Horton, W. B., Love, K. M., Gregory, J. M., Liu, Z., & Barrett, E. J. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00826.2024 · Cited by 95
Metadata
- Authors
- Gray, S. P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A. C., de Haan, J. B., Koulis, C., El-Osta, A., Andrews, K. L., Chin-Dusting, J. P. F., Touyz, R. M., Wingler, K., Cooper, M. E., Schmidt, H. H. H. W., & Jandeleit-Dahm, K. A.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- From the Diabetic Complications Division, Baker IDI Heart & Diabetes Institute, Melbourne, Australia (S.P.G., E.D.M., J.B.d.H., C.K., M.E.C., K.A.J.-D.); the Department of Medicine, Monash University, Monash, Australia (E.D.M., M.E.C., K.A.J.-D.); Epigenetics in Human Health and Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Australia (J.O., A.E.-O.); GenKyoTex SA, Geneva, Switzerland (C.S., F.H.); Ottawa Hospital Research Institute, Ottawa, Canada (A.C.M., R.M.T.); Institute of...
- ORCID
- Venue
- Circulation
- Published
- 2013-05-07
- Volume
- 127
- Issue
- 18
- Pages
- 1888-1902
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2137012624
- Cited by
- 386
- References
- 56
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 24 · 2023: 17 · 2022: 20 · 2021: 29 · 2020: 41 · 2019: 28 · 2018: 24 · 2017: 33 · 2016: 37 · 2015: 43 · 2014: 39 · 2013: 16
- FWCI
- 31.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Diabetes Australia Research Trust
- Ottawa Hospital Research Institute
- Diabetes Australia
- National Heart Foundation of Australia
- Université de Genève
- Canadian Institutes of Health Research
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- NOX1, diabetic atherosclerosis, hyperglycemia, oxidative stress, reactive oxygen species, GKT137831, aortic endothelial cells, ApoE-deficient mice, atherosclerotic plaque, chemokine expression, leukocyte adhesion, macrophage infiltration, vascular inflammation
- MeSH terms
- NADPH Oxidase 1, Animals, Cells, Cultured, Diabetes Mellitus, Experimental, Humans, Male, Mice, Transgenic, NADH, NADPH Oxidoreductases, Organ Culture Techniques, Reactive Oxygen Species, Mice, Knockout, Inflammation Mediators, NADPH Oxidases, Protein Isoforms, Endothelial Cells, Atherosclerosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
